Di Sera, Tonya
Velinder, Matt
Ward, Alistair
Qiao, Yi
Georges, Stephanie
Miller, Chase
Pitman, Anders
Richards, Will
Ekawade, Aditya
Viskochil, David
Carey, John C.
Pace, Laura
Bale, Jim
Clardy, Stacey L.
Andrews, Ashley
Botto, Lorenzo
Marth, Gabor
Funding for this research was provided by:
National Human Genome Research Institute (5R01HG009000, 5R01HG009000, 5R01HG009000, 5R01HG009000, 5R01HG009000, 5R01HG009000, 5R01HG009000, 5R01HG009000, 5R01HG009000, 5R01HG009000)
Article History
Received: 7 April 2021
Accepted: 3 September 2021
First Online: 13 October 2021
Change Date: 6 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-022-09959-3
Competing interests
: Gabor Marth is a founder and chief scientific officer of Frameshift Labs, Inc. and Alistair Ward is a founder and chief executive officer of Frameshift Labs, Inc.